| 产品编号 | 图片 | CAS No. | 名称及描述 | 规格 | 价格 | 分子式 | 快速订购 |
|---|---|---|---|---|---|---|---|
| GC43373-250mg |
|
39793-31-2 |
D-Amino Acid Oxidase Inhibitor - Glpbio |
0 | 需询价 | C7H5NO2S | |
| GC43372-1mg |
|
205391-01-1 |
DAF-2 - Glpbio |
0 | 需询价 | C20H14N2O5 | |
| GC43372-500μg |
|
205391-01-1 |
DAF-2 - Glpbio |
0 | 需询价 | C20H14N2O5 | |
| GC43372-250μg |
|
205391-01-1 |
DAF-2 - Glpbio |
0 | 需询价 | C20H14N2O5 | |
| GC43372-100μg |
|
205391-01-1 |
DAF-2 - Glpbio |
0 | 需询价 | C20H14N2O5 | |
| GC43371-1mg |
|
1015167-40-4 |
Dabigatran Acyl-β-D-Glucuronide - Glpbio |
0 | 需询价 | C31H33N7O9 | |
| GC43370-500μg |
|
— |
Dabcyl-RGVVNASSRLA-EDANS (trifluoroacetate salt) - Glpbio |
0 | 需询价 | C73H109N23O18S&;XCF3COOH | |
| GC43369-1mg |
|
— |
Dabcyl-GABA-RPKPVE-Nva-WR-Glu(EDANS)-AK-NH2 (trifluoroacetate salt) - Glpbio |
0 | 需询价 | C99H144N28O20S&;XCF3COOH | |
| GC43369-500μg |
|
— |
Dabcyl-GABA-RPKPVE-Nva-WR-Glu(EDANS)-AK-NH2 (trifluoroacetate salt) - Glpbio |
0 | 需询价 | C99H144N28O20S&;XCF3COOH | |
| GC43368-25mg |
|
52946-22-2 |
D,L-1′-Acetoxychavicol Acetate - Glpbio |
0 | 需询价 | C13H14O4 | |
| GC43368-10mg |
|
52946-22-2 |
D,L-1′-Acetoxychavicol Acetate - Glpbio |
0 | 需询价 | C13H14O4 | |
| GC43368-5mg |
|
52946-22-2 |
D,L-1′-Acetoxychavicol Acetate - Glpbio |
0 | 需询价 | C13H14O4 | |
| GC43368-1mg |
|
52946-22-2 |
D,L-1′-Acetoxychavicol Acetate - Glpbio |
0 | 需询价 | C13H14O4 | |
| GC43367-1g |
|
110187-42-3 |
D-(+)-Glucose-13C6 - Glpbio |
0 | 需询价 | [13C]6H12O6 | |
| GC43367-500mg |
|
110187-42-3 |
D-(+)-Glucose-13C6 - Glpbio |
0 | 需询价 | [13C]6H12O6 | |
| GC43367-250mg |
|
110187-42-3 |
D-(+)-Glucose-13C6 - Glpbio |
0 | 需询价 | [13C]6H12O6 | |
| GC43367-100mg |
|
110187-42-3 |
D-(+)-Glucose-13C6 - Glpbio |
0 | 需询价 | [13C]6H12O6 | |
| GC43366-25mg |
|
— |
D-(-)-Citramalic Acid (lithium salt) - Glpbio |
0 | 需询价 | C5H8O5&;XLi | |
| GC43366-10mg |
|
— |
D-(-)-Citramalic Acid (lithium salt) - Glpbio |
0 | 需询价 | C5H8O5&;XLi | |
| GC43366-5mg |
|
— |
D-(-)-Citramalic Acid (lithium salt) - Glpbio |
0 | 需询价 | C5H8O5&;XLi | |
小泰
|
010-60710855
|